207 related articles for article (PubMed ID: 26050046)
1. Volumetric intensity-modulated arc therapy vs. 3-dimensional conformal radiotherapy for primary chemoradiotherapy of anal carcinoma: Effects on treatment-related side effects and survival.
Weber HE; Dröge LH; Hennies S; Herrmann MK; Gaedcke J; Wolff HA
Strahlenther Onkol; 2015 Nov; 191(11):827-34. PubMed ID: 26050046
[TBL] [Abstract][Full Text] [Related]
2. [Short-term efficacy comparison between preoperative three dimensional conformal radiotherapy and volumetric modulated arc therapy concurrently combined with chemotherapy in the treatment of locally advanced rectal carcinoma].
Xiao L; Yu X; Zhu Y; Xiao W; Zeng Z; Liu M; Zhang R; Gao Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):769-75. PubMed ID: 27452754
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of cetuximab in combination with 5-fluorouracil, mitomycin C and radiotherapy in patients with locally advanced anal cancer.
Leon O; Guren MG; Radu C; Gunnlaugsson A; Johnsson A
Eur J Cancer; 2015 Dec; 51(18):2740-6. PubMed ID: 26597443
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of acute toxicity and quality of life after IMRT and concurrent chemotherapy for anal canal and perianal cancer.
Han K; Cummings BJ; Lindsay P; Skliarenko J; Craig T; Le LW; Brierley J; Wong R; Dinniwell R; Bayley AJ; Dawson LA; Ringash J; Krzyzanowska MK; Moore MJ; Chen EX; Easson AM; Kassam Z; Cho C; Kim J
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):587-94. PubMed ID: 25194664
[TBL] [Abstract][Full Text] [Related]
5. Volumetric modulated arc therapy (VMAT) in the combined modality treatment of anal cancer patients.
Franco P; Arcadipane F; Ragona R; Mistrangelo M; Cassoni P; Munoz F; Rondi N; Morino M; Racca P; Ricardi U
Br J Radiol; 2016; 89(1060):20150832. PubMed ID: 26838953
[TBL] [Abstract][Full Text] [Related]
6. Locally Advanced (T3-T4 or N+) Anal Cancer Treated with Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy.
Franco P; Arcadipane F; Ragona R; Mistrangelo M; Cassoni P; Rondi N; Morino M; Racca P; Ricardi U
Anticancer Res; 2016 Apr; 36(4):2027-32. PubMed ID: 27069197
[TBL] [Abstract][Full Text] [Related]
7. Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal.
Agarwal MS; Hitchcock KE; Morris CG; George TJ; Mendenhall WM; Zlotecki RA
Curr Oncol; 2019 Aug; 26(4):e515-e521. PubMed ID: 31548820
[TBL] [Abstract][Full Text] [Related]
8. Conventional 3D conformal radiotherapy and volumetric modulated arc therapy for cervical cancer: Comparison of clinical results with special consideration of the influence of patient- and treatment-related parameters.
Dröge LH; von Sivers FF; Schirmer MA; Wolff HA
Strahlenther Onkol; 2021 Jun; 197(6):520-527. PubMed ID: 33938967
[TBL] [Abstract][Full Text] [Related]
9. Haematotoxicity in IMRT/VMAT curatively treated anal cancer.
Lohynská R; Nýdlová A; Drbohlavová T; Mazaná E; Jirkovská M; Veselský T; Malinová B; Stankušová H
Klin Onkol; 2020; 33(4):288-294. PubMed ID: 32894958
[TBL] [Abstract][Full Text] [Related]
10. Intensity-modulated Radiotherapy for Anal Cancer: Dose-Volume Relationship of Acute Gastrointestinal Toxicity and Disease Outcomes.
Ng M; Ho H; Skelton J; Guerrieri M; Guiney M; Chao M; Blakey D; Macleod C; Amor H; Subramanian B; Melven L
Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):634-641. PubMed ID: 30049649
[TBL] [Abstract][Full Text] [Related]
11. Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy.
Dröge LH; Weber HE; Guhlich M; Leu M; Conradi LC; Gaedcke J; Hennies S; Herrmann MK; Rave-Fränk M; Wolff HA
BMC Cancer; 2015 Oct; 15():750. PubMed ID: 26486986
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia and dosimetric parameters in relation to treatment-related leukopenia and survival in anal cancer.
Nilsson MP; Johnsson A; Scherman J
Radiat Oncol; 2021 Aug; 16(1):152. PubMed ID: 34399812
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of patients with anal cancer treated with volumetric-modulated arc therapy or intensity-modulated radiotherapy and concurrent chemotherapy.
Yucel S; Kadioglu H; Gural Z; Akgun Z; Saglam EK
J Cancer Res Ther; 2021; 17(1):51-55. PubMed ID: 33723132
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of definitive radiation with volumetric modulated arc therapy and concurrent chemotherapy for squamous cell carcinoma of the anus in a regional Australian cancer centre.
Hsieh MT; Shakespeare TP; Winkley L; Goonetilleke D; Yap SZL; Tahir ARM
J Med Imaging Radiat Oncol; 2024 Apr; 68(3):325-332. PubMed ID: 38450897
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients.
De Bari B; Jumeau R; Bouchaab H; Vallet V; Matzinger O; Troussier I; Mirimanoff RO; Wagner AD; Hanhloser D; Bourhis J; Ozsahin EM
Acta Oncol; 2016 Jun; 55(6):767-73. PubMed ID: 27034083
[TBL] [Abstract][Full Text] [Related]
16. Can advanced new radiation therapy technologies improve outcome of high grade glioma (HGG) patients? analysis of 3D-conformal radiotherapy (3DCRT) versus volumetric-modulated arc therapy (VMAT) in patients treated with surgery, concomitant and adjuvant chemo-radiotherapy.
Navarria P; Pessina F; Cozzi L; Ascolese AM; Lobefalo F; Stravato A; D'Agostino G; Franzese C; Caroli M; Bello L; Scorsetti M
BMC Cancer; 2016 Jun; 16():362. PubMed ID: 27287048
[TBL] [Abstract][Full Text] [Related]
17. French multicentre clinical evaluation of helical TomoTherapy for anal cancer in a cohort of 64 consecutive patients.
Vendrely V; Henriques de Figueiredo B; Rio E; Benech J; Belhomme S; Lisbona A; Frison E; Doussau A; Nomikossoff N; Mahé MA; Kantor G; Maire JP
Radiat Oncol; 2015 Aug; 10():170. PubMed ID: 26268888
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant volumetric modulated arc therapy compared to 3D conformal radiation therapy for newly diagnosed soft tissue sarcoma of the extremities: outcome and toxicity evaluation.
Di Brina L; Fogliata A; Navarria P; D'Agostino G; Franzese C; Franceschini D; De Rose F; Comito T; Bertuzzi A; Marrari A; Colombo P; Quagliuolo V; Santoro A; Scorsetti M
Br J Radiol; 2019 Oct; 92(1102):20190252. PubMed ID: 31322910
[TBL] [Abstract][Full Text] [Related]
19. [Management of locally advanced anal canal carcinoma with modulated arctherapy and concurrent chemotherapy].
Troussier I; Huguet F; Servagi-Vernat S; Benahim C; Khalifa J; Darmon I; Ortholan C; Krebs L; Dejean C; Fenoglietto P; Vieillot S; Bensadoun RJ; Thariat J
Cancer Radiother; 2015 Apr; 19(2):127-38. PubMed ID: 25770884
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy.
Tozzi A; Cozzi L; Iftode C; Ascolese A; Campisi MC; Clerici E; Comito T; De Rose F; Fogliata A; Franzese C; Mancosu P; Navarria P; Tomatis S; Villa E; Scorsetti M
BMC Cancer; 2014 Nov; 14():833. PubMed ID: 25403766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]